Defining element
Creatine
How to think about creatine kidney safety, blood tests and risk factors without either panic or false reassurance.

Kidney safety refers to whether creatine use harms kidney structure or filtration. Serum creatinine alone cannot answer that question because creatine supplementation can influence the marker itself.
Healthy-adult safety evidence is reassuring, while higher-risk groups require more individualized interpretation.
Use this map to move through the concept in a clear order: meaning, mechanism, use, and wider context.
Creatine and kidney safety are often discussed together because creatine supplementation can influence serum creatinine, a common kidney-related blood marker. That creates an easy misunderstanding: a higher creatinine value can look like worse kidney function even when the supplement has not injured the kidneys.
Controlled trials and reviews generally report that standard studied creatine monohydrate doses are well tolerated in healthy adults, without a consistent pattern of kidney injury. That is reassuring, but it should not be turned into the blanket statement that creatine is safe for every person in every situation.
Women with established kidney disease, prior kidney injury or medically complex conditions are not represented well enough in routine supplement studies to justify the same assumptions.
Kidney-safety studies commonly track serum creatinine, estimated glomerular filtration rate, blood urea nitrogen, urine markers and sometimes other laboratory measures. Some trials also monitor adverse events over weeks or months.
One limitation is duration. Most supplementation studies are much shorter than the years or decades over which many people may choose to use creatine. Another is participant selection: healthier people are more likely to be included than those with significant kidney disease.
That means “no signal of harm in healthy users” is a stronger statement than “proven safe in every population.” Good evidence writing keeps those two claims separate.
A 2025 systematic review and meta-analysis of creatine and kidney function reported a modest rise in serum creatinine without a statistically significant change in measured glomerular filtration outcomes across the included studies. The authors also noted that long-term evidence remains limited. This distinction matters because a creatinine-based estimate can change without conclusively demonstrating kidney injury; it does not mean people with existing kidney disease can assume supplementation is risk-free. For a closer explanation of laboratory interpretation, see Mayobook’s creatine and eGFR blood-test reference, and discuss unexpected results or underlying kidney risks with a clinician.
Creatine and creatinine are related compounds. A small amount of creatine naturally converts to creatinine every day. When the body’s creatine pool increases, creatinine production can also change.
Because creatinine is used in common eGFR equations, a creatinine increase can make estimated kidney filtration appear lower. Muscle mass, hard exercise, diet and hydration also affect creatinine. That is why a single result needs interpretation rather than an automatic diagnosis.
Women with chronic kidney disease, a history of kidney injury, uncontrolled hypertension, diabetes with kidney complications, pregnancy or medications that can affect kidney function should seek individualized guidance before using creatine.
The same caution applies to women with persistently abnormal kidney tests. Creatine may explain part of a creatinine change, but it should not be used to dismiss a pattern that needs medical evaluation.
Serum creatinine is only one piece of the picture. Depending on the clinical situation, a clinician may consider creatinine-based eGFR trends, urine albumin or protein, cystatin C, blood pressure, symptoms and repeat testing.
Trend matters. A stable result over time can mean something different from a progressive change. The key is not to chase one “perfect” number but to interpret the pattern in context.
There is no need to dehydrate, stop prescribed medication or manipulate a testing routine simply to change a lab result.
Creatine has often been accused of causing dehydration or cramping, but controlled evidence does not support the idea that standard creatine use inherently dehydrates healthy exercisers. Hydration still matters during heat and exercise, but the supplement itself does not create a special need to force huge amounts of water.
Protein intake and creatine use are often discussed together because many active women use both. A higher-protein diet does not automatically mean the kidneys are being damaged, but women with known kidney disease may have individualized protein recommendations.
The important point is that creatine safety should not be judged through assumptions about protein alone. Kidney risk depends on the whole clinical picture.
Creatine monohydrate is simple, but combination products may contain stimulants, herbs, electrolytes or other active ingredients. If symptoms or abnormal labs develop after starting a multi-ingredient product, it may be difficult to know which ingredient contributed.
Choosing a clearly labeled, third-party-tested creatine product reduces unnecessary uncertainty even though product testing cannot guarantee a clinical outcome.
Persistent abnormal kidney markers, swelling, reduced urine output, serious illness, pregnancy, known kidney disease or complex medication use deserve professional assessment. These are not situations to manage by simply changing supplement timing.
Research in healthy women can answer whether routine creatine use commonly causes kidney injury in that population. It cannot automatically establish safety in chronic kidney disease, pregnancy or every medication combination. Evidence should be applied to the population that was actually studied.
This is especially important when online advice says either “creatine destroys kidneys” or “creatine is always safe.” Both statements erase the difference between healthy users and people with meaningful medical risk.
For broader Mayobook coverage of strength, exercise and body transformation, explore the Fitness, Weight Loss & Body Transformation topic hub.
Healthy women do not necessarily need special kidney testing simply because they use creatine. Monitoring should follow ordinary clinical indications, personal risk factors and a clinician’s judgment. The important exception is when kidney-related tests are already being performed: in that situation, creatine use should be disclosed so serum creatinine and eGFR are interpreted appropriately.
Women who have a family history of kidney disease, hypertension, diabetes or prior abnormal kidney results may already have reasons for periodic monitoring independent of creatine.
For healthy women, kidney-safety evidence for standard creatine use is generally reassuring. The bigger practical issue is often lab interpretation: creatine can influence serum creatinine and therefore creatinine-based eGFR. Higher-risk women need individualized guidance instead of general supplement assumptions.
Creatine
Creatinine
eGFR
Cystatin C
A creatinine change is not the same as proven kidney injury.
Use these connected pages for the next step.

See how this concept fits into the broader…
Explore topic →Standard studied doses have not shown a consistent pattern of kidney damage in healthy adults.
A portion of creatine converts naturally to creatinine, so supplementation can influence the blood marker.
Yes. Creatinine-based eGFR can shift when serum creatinine changes.
Women with kidney disease, pregnancy, significant medical conditions or complex medication use should seek individualized guidance.
Controlled evidence does not show that standard creatine use inherently dehydrates healthy exercisers.
Follow the ordering clinician's instructions and disclose supplement use rather than changing the testing plan on your own.
Kidney-safety guidance should be evidence-based and contextual rather than driven by either supplement fear or supplement marketing.